In 2016, FDA published its risk assessment on the health risks of inorganic arsenic in rice and rice products. The assessment provides a quantitative estimate of lung and bladder cancer risk from long-term exposure to inorganic arsenic, and a qualitative assessment of potential non-cancer risks in certain vulnerable life stages.